Literature DB >> 12565770

The influence of serial sections, immunohistochemistry, and extension of pelvic lymph node dissection on the lymph node status in clinically localized prostate cancer.

Friedhelm Wawroschek1, Theodor Wagner, Michael Hamm, Dorothea Weckermann, Harry Vogt, Bruno Märkl, Ronald Gordijn, Rolf Harzmann.   

Abstract

OBJECTIVES: Pelvic lymph node metastases indicate a poor prognosis for patients with clinically localized prostate cancer. The aim of the study was to investigate the value of extended histopathological techniques considering the extent of pelvic lymphadenectomy and preoperative risk factors.
METHODS: Total of 194 patients with prostate cancer were examined. At first all patients had a sampling of the sentinel lymph nodes (SLN) followed in most cases by a modified or extended pelvic lymphadenectomy. Step sections, serial sections and immunohistochemistry (IHC, pancytokeratin antibody) were analyzed in all SLN and so-called non-SLN of the first 100 patients. Later serial sections and IHC of non-SLN were left out.
RESULTS: In 26.8% lymphatic metastases were found. The detection rate of lymph node-positive patients depend significantly on the chosen extension of pelvic lymphadenectomy. Limiting the histopathological investigation to the lymph node specimen of the obturator fossa only 44.2% of lymph node-positive cases would have been identified. An additional inclusion of all lymph nodes surrounding the external iliac vessels improves the sensitivity to 65.4% (46.7% and 73.3% for the first 100 patients). Compared to the extension of pelvic lymphadenectomy the diagnostic gain of serial section and IHC (13.8% versus 53.3%) was comparably low.
CONCLUSIONS: The extension of pelvic lymph node dissection is of outstanding value for the identification of node-positive patients. Limiting the number of lymph nodes to the ones with the highest probability of bearing lymphatic spread (SLN) makes the use of extensive histopathological techniques more feasible.

Entities:  

Mesh:

Year:  2003        PMID: 12565770     DOI: 10.1016/s0302-2838(02)00450-5

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  28 in total

Review 1.  Isolated, disseminated and circulating tumour cells in prostate cancer.

Authors:  David Schilling; Tilman Todenhöfer; Jörg Hennenlotter; Christian Schwentner; Tanja Fehm; Arnulf Stenzl
Journal:  Nat Rev Urol       Date:  2012-07-10       Impact factor: 14.432

Review 2.  Update on histopathological evaluation of lymphadenectomy specimens from prostate cancer patients.

Authors:  Alessandro Conti; Matteo Santoni; Luciano Burattini; Marina Scarpelli; Roberta Mazzucchelli; Andrea B Galosi; Liang Cheng; Antonio Lopez-Beltran; Alberto Briganti; Francesco Montorsi; Rodolfo Montironi
Journal:  World J Urol       Date:  2015-12-22       Impact factor: 4.226

3.  Sentinel lymph node dissection combined with meticulous histology increases the detection rate of nodal metastases in prostate cancer.

Authors:  Michal Staník; Ivo Čapák; Daniel Macík; Jiří Vašina; Eva Lžičařová; Jiří Jarkovský; Martin Šustr; David Miklánek; Jan Doležel
Journal:  Int Urol Nephrol       Date:  2014-03-29       Impact factor: 2.370

4.  Radioguided sentinel lymph node dissection in patients with localised prostate carcinoma: influence of the dose of radiolabelled colloid to avoid failure of the procedure.

Authors:  Isabelle Brenot-Rossi; Dominique Rossi; Benjamin Esterni; Serge Brunelle; Guillaume Chuto; Cyrille Bastide
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-09-09       Impact factor: 9.236

Review 5.  A systematic review and meta-analysis of comparative studies on the efficacy of extended pelvic lymph node dissection in patients with clinically localized prostatic carcinoma.

Authors:  Liang Gao; Lu Yang; Xiao Lv; Siyuan Bu; Fan Wan; Shengqiang Qian; Qiang Wei; Ping Han; Tianyong Fan
Journal:  J Cancer Res Clin Oncol       Date:  2013-12-27       Impact factor: 4.553

6.  Histological step sectioning of pelvic lymph nodes increases the number of identified lymph node metastases.

Authors:  Birte Engvad; Mads H Poulsen; Pia W Staun; Steen Walter; Niels Marcussen
Journal:  Virchows Arch       Date:  2013-11-21       Impact factor: 4.064

Review 7.  Sentinel node evaluation in prostate cancer.

Authors:  Ramkishen Narayanan; Timothy G Wilson
Journal:  Clin Exp Metastasis       Date:  2018-09-05       Impact factor: 5.150

8.  Limited pelvic lymphadenectomy using the sentinel lymph node procedure in patients with localised prostate carcinoma: a pilot study.

Authors:  Isabelle Brenot-Rossi; Cyril Bastide; Stephane Garcia; Stephane Dumas; Benjamin Esterni; Jacques Pasquier; Dominique Rossi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-03-04       Impact factor: 9.236

Review 9.  Extended lymph node dissection for prostate cancer.

Authors:  Stephan Jeschke; Fiona C Burkhard; Ramesh Thurairaja; Nivedita Dhar; Urs E Studer
Journal:  Curr Urol Rep       Date:  2008-05       Impact factor: 3.092

Review 10.  [Sentinel node dissection in prostate cancer: current status].

Authors:  D Weckermann; G Holl; T Wagner; R Harzmann
Journal:  Urologe A       Date:  2007-11       Impact factor: 0.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.